Stefania Croci
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology top 10%
- Immunology top 5%
- Oncology top 5%
- Rheumatology top 5%
- Co-authors
- Pier‐Luigi LolliniGiordano NicolettiLorena LanduzziCarla De GiovanniPatrizia NanniCarlo SalvaraniAnnalisa AstolfiFrancesco Muratore
- Topics
- Vasculitis and related conditions (32 papers)Immunotherapy and Immune Responses (20 papers)Otitis Media and Relapsing Polychondritis (12 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Stefania Croci
105 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Pulmonary and Respiratory Medicine 835
- Molecular Biology 733
- Immunology 542
- Oncology 518
- Rheumatology 353
Countries citing papers authored by Stefania Croci
This map shows the geographic impact of Stefania Croci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Croci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Croci more than expected).
Fields of papers citing papers by Stefania Croci
This network shows the impact of papers produced by Stefania Croci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Croci. The network helps show where Stefania Croci may publish in the future.
Co-authorship network of co-authors of Stefania Croci
This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Croci. A scholar is included among the top collaborators of Stefania Croci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Croci. Stefania Croci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 6 | |
| 7 | 3 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 12 | |
| 11 | 18 | |
| 12 | 10 | |
| 13 | 6 | |
| 14 | 11 | |
| 15 | Imbalance between angiogenic and anti-angiogenic factors in sera from patients with large-vessel vasculitis. | 14 |
| 16 | 34 | |
| 17 | 43 | |
| 18 | 69 | |
| 19 | 77 | |
| 20 | 64 |
About Stefania Croci
Stefania Croci is a scholar working on Immunology and Allergy, Rheumatology and Immunology, having authored 109 papers that have together received 2.4k indexed citations. Recurring topics across this work include Vasculitis and related conditions (32 papers), Immunotherapy and Immune Responses (20 papers) and Otitis Media and Relapsing Polychondritis (12 papers). The work is most often cited by research in Immunology (542 citations), Pulmonary and Respiratory Medicine (835 citations) and Rheumatology (353 citations). Stefania Croci has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Pier‐Luigi Lollini, Giordano Nicoletti, Lorena Landuzzi, Carla De Giovanni, Patrizia Nanni, Carlo Salvarani, Annalisa Astolfi, Francesco Muratore, Manuela Iezzi and Arianna Palladini. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.